Stem Cell & Cellular Therapy
Tissue regeneration and functional recovery through mesenchymal and neural stem cell approaches. Clinical research in spinal cord injury, hypoxic-ischemic brain damage and neuroregeneration is conducted within a framework of scientific realism, safety and appropriate candidate selection.
Introduction to Cellular Therapy
Regenerative medicine is a contemporary approach that aims to repair damaged tissues and organs by supporting the body's own capacity to heal. Rather than simply suppressing symptoms, cellular therapy seeks to influence the tissue microenvironment and encourage natural repair processes. This philosophy views disease not as an isolated point of failure but as part of a biological whole, and it advances with scientific realism.
A significant portion of applications in this field remains at the research and clinical-evaluation stage. The goal is to support the body's regenerative potential through evidence-based protocols conducted within safe and ethical frameworks. Cellular therapy is not a miracle or a guarantee of recovery; it is being investigated as a complementary option for carefully selected, appropriate candidates.
The work carried out by Prof. Dr. Erdinç Civelek focuses on core mechanisms such as mesenchymal stem cells, exosomes and immunomodulation. The aim is to translate laboratory findings into meaningful, responsible medical knowledge through rigorous scientific methods, prioritizing patient safety at every stage.
Mesenchymal Stem Cells (MSCs)
Mesenchymal stem cells sit at the heart of regenerative medicine because of their ability to develop into different tissue types and to signal to neighbouring cells. These cells are being investigated less for directly building new tissue and more for the bioactive molecules they secrete, which may help regulate inflammation, support blood-vessel formation and encourage a repair-friendly environment.
MSCs can be obtained from several sources. Wharton's jelly (the connective tissue of the umbilical cord) stands out as a young, highly proliferative and ethically accessible source. Bone marrow carries a long clinical track record, while adipose (fat) tissue offers a relatively accessible option. Each source has its own biological characteristics and research contexts.
Prof. Dr. Civelek's scientific work focuses in particular on the immunomodulatory and neuroregenerative potential of Wharton's-jelly-derived mesenchymal stem cells. The exosomes and growth factors these cells secrete represent a promising but still investigational area of research aimed at supporting nervous-system repair.
Spinal Cord Injury
Spinal cord injury is one of the most challenging areas of neurological medicine because nervous tissue has a limited capacity to renew itself. Cellular therapy research aims to soften the damaging inflammatory environment at the injury site, support the survival of nerve cells and help create a microenvironment more favourable to repair.
In experimental models, mesenchymal stem cells and their exosome derivatives have been reported to show neuroprotective and inflammation-regulating effects. Functional-recovery goals are built around gradual gains in sensation, movement and quality of life. However, most of these approaches remain investigational and do not offer any guarantee of full recovery.
For this reason, cellular approaches in spinal cord injury do not replace standard neurosurgical and rehabilitative care; they are considered as a complement to it, within the framework of appropriate candidate selection and ethically approved protocols. Each patient's level and duration of injury and overall condition are carefully evaluated on an individual basis.
Intervertebral Disc Regeneration
The intervertebral discs between the vertebrae degenerate with age and mechanical load, a process that is a major cause of back and neck pain. While conventional treatments largely focus on managing symptoms, cell-based approaches aim to support the underlying biological process that drives degeneration.
Research is investigating how mesenchymal stem cells may support the cells within the disc, encourage matrix production and help regulate inflammation. The goal is to contribute to pain reduction and the preservation of function by supporting the disc's ability to retain water and bear load. This rests on the idea of improving the biological environment rather than fully rebuilding a damaged disc.
Cellular applications for disc regeneration remain at the research and clinical-evaluation stage. Suitability is determined individually, based on the degree of degeneration, the patient's overall spinal health and their response to other treatments, and it is always offered within a scientific framework.
From Laboratory to Clinic
The reliability of cellular therapy begins with rigorous laboratory processes. Once cells are obtained from an appropriate source, they are processed and expanded in controlled, sterile conditions and tested for viability, identity and microbiological safety. Good Manufacturing Practice (GMP) standards aim to guarantee the quality and consistency of the product.
The treatment journey starts with a comprehensive medical assessment of the patient. History, imaging and laboratory findings are reviewed together to evaluate a candidate's suitability. Expectations are discussed openly; potential benefits are shared as transparently as the limitations and risks. Informed consent is an inseparable part of this process.
Follow-up after the procedure is a critical stage. Tracking the response with objective measures, continuously monitoring safety and adapting the plan when needed are essential. This holistic approach positions cellular therapy not as a random intervention but as a carefully structured medical process.
Safety, Candidate Selection and the Scientific Framework
Safety and appropriate candidate selection are the highest priorities in cellular therapy. Not every patient is suitable for these approaches; active infection, uncontrolled cancer or certain health conditions may make the procedure inadvisable. Suitability is determined individually, through comprehensive assessment and an honest discussion of risks and benefits.
Cellular therapy does not replace evidence-based standard care; it is considered as a complement to it, but only within a framework of scientific rationale and clinical oversight. Established methods such as surgery, medication and rehabilitation are not neglected. The aim is to support the best available care, not to substitute for it.
This field is tightly framed by ethical principles and regulatory approvals. Responsible practice requires unexaggerated information, realistic expectations and transparency. Promises of miracles are avoided; instead an honest, science-based path is followed. Prof. Dr. Civelek's approach is shaped on this foundation of scientific realism and patient safety.
You may request an appointment for an assessment or a second opinion on this subject.
Request Appointment